Metabolic genetic polymorphisms and susceptibility to lung cancer

被引：36
|
作者：
Bouchardy, C
Benhamou, S
Jourenkova, N
Dayer, P
Hirvonen, A
机构：
[1] Geneva Canc Registry, CH-1205 Geneva, Switzerland
[2] Inst Gustave Roussy, Canc Epidemiol Unit, INSERM U521, Villejuif, France
[3] Univ Hosp Geneva, Div Clin Pharmacol, Geneva, Switzerland
[4] Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, Helsinki, Finland
来源：
LUNG CANCER | 2001年 / 32卷 / 02期
关键词：
lung cancer; carcinogen; metabolism; enzyme; genotype; polymorphism; tobacco consumption; epidemiology;
D O I：
10.1016/S0169-5002(00)00215-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Activity of some enzymes implicated in the metabolism of tobacco carcinogens presents a great variability between individuals due to the existence of a polymorphism in gene coding for these enzymes. Individual susceptibility to develop lung cancer could therefore depend not only on exposure to tobacco smoking, but also on genetic capacity to activate or inactivate tobacco carcinogens. This article summarizes the state of knowledge on metabolic polymorphisms and lung cancer susceptibility, and opens the discussion on the future direction of this promising way of research. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
下载
收藏
页码：109 / 112
页数：4
相关论文
共 50 条
  • [1] Genetic polymorphisms and lung cancer susceptibility: a review
    Kiyohara, C
    Otsu, A
    Shirakawa, T
    Fukuda, S
    Hopkin, JM
    LUNG CANCER, 2002, 37 (03) : 241 - 256
  • [2] Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility
    Mota, P.
    Silva, H. C.
    Soares, M. J.
    Pego, A.
    Loureiro, M.
    Robalo Cordeiro, C.
    Regateiro, F. J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (05) : 851 - 860
  • [3] Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility
    P. Mota
    H. C. Silva
    M. J. Soares
    A. Pego
    M. Loureiro
    C. Robalo Cordeiro
    F. J. Regateiro
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 851 - 860
  • [4] Metabolic polymorphisms and cancer susceptibility
    Smith, G
    Stanley, LA
    Sim, E
    Strange, RC
    Wolf, CR
    CANCER SURVEYS, 1995, 25 : 27 - 65
  • [5] Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China
    Chen, Han-chun
    Cao, Yan-fei
    Hu, Wei-xin
    Liu, Xin-fa
    Liu, Qing-xia
    Zhang, Ji
    Liu, Jia
    DISEASE MARKERS, 2006, 22 (03) : 141 - 152
  • [6] Correlation between survivin genetic polymorphisms and lung cancer susceptibility
    Guo, Guifang
    Zhang, Qiang
    Yu, Zhengang
    Li, Junjuan
    Ding, Zhaolei
    Li, Juan
    Tan, Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 7426 - 7430
  • [7] Genetic polymorphisms and susceptibility to lung disease
    Lee, Pauline L.
    West, Carol
    Crain, Karen
    Wang, Lei
    JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE, 2006, 5
  • [8] Genetic polymorphisms of CYP1A1 and susceptibility of lung Cancer
    Hu, Yiling
    Zhang, Qiao
    Zhonghua Yixue Yichuanxue Zazhi/Chinese Journal of Medical Genetics, 1999, 16 (01): : 26 - 28
  • [9] GENETIC POLYMORPHISMS AND SUSCEPTIBILITY TO CANCER DEVELOPMENT
    SUGIMURA, T
    INOUE, R
    OHGAKI, H
    USHIJIMA, T
    CANZIAN, F
    NAGAO, M
    PHARMACOGENETICS, 1995, 5 : S161 - S165
  • [10] Significance of genetic polymorphisms in cancer susceptibility
    Hietanen, E
    ADVANCES IN NUTRITION AND CANCER 2, 1999, 472 : 241 - 251
12345